Tvardi Therapeutics (TVRD) Misses Q1 EPS by 73c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts TVRD Hot Sheet
Join SI Premium – FREE
Tvardi Therapeutics (NASDAQ: TVRD) reported Q1 EPS of ($0.73).
For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Highlights Top Mid-Cap Biotech Stocks Ahead of Earnings
- Needham Starts Kontoor Brands (KTB) at Hold
- M&T Bank Corp. (MTB) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
